Amanote Research

Amanote Research

    RegisterSign In

Factors XI and XII as Targets for New Anticoagulants

Frontiers in Medicine - Switzerland
doi 10.3389/fmed.2017.00019
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

February 24, 2017

Authors
Jeffrey I. WeitzJames C. Fredenburgh
Publisher

Frontiers Media SA


Related search

Factor XI and XII as Antithrombotic Targets

Current Opinion in Hematology
Hematology
2011English

Cornellii Taciti, Annalium Libri XI-XII

Estudios: filosofía, historia, letras
2011English

Fabrication and Characterization of Planar Cryogenic Targets for GEKKO-XII

Journal of Physics: Conference Series
AstronomyPhysics
2008English

New Anticoagulants for Atrial Fibrillation

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2009English

RASKOPKI MUSUL'MANSKOGO POGREBENIYa XI–XII VV. V DERBENTE

History, Archeology and Ethnography of the Caucasus
2013English

New Anticoagulants and Antiplatelet Agents

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2004English

CB2 Receptors as New Therapeutic Targets for Liver Diseases

British Journal of Pharmacology
Pharmacology
2008English

P2X Receptors as New Therapeutic Targets

2011English

Ion Pumps as Targets for Therapeutic Intervention: Old and New Paradigms

Electronic Journal of Biotechnology
Applied MicrobiologyBiotechnology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy